ROG logo

Roche Holding Stock Price

Symbol: SWX:ROGMarket Cap: CHF 221.1bCategory: Pharmaceuticals & Biotech

ROG Share Price Performance

CHF 257.10
-12.90 (-4.78%)
14.9% undervalued intrinsic discount
CHF 302.06
Fair Value
CHF 257.10
-12.90 (-4.78%)
14.9% undervalued intrinsic discount
CHF 302.06
Fair Value
Price CHF 257.10
bazza CHF 302.06
AnalystConsensusTarget CHF 300.29
AnalystLowTarget CHF 220.00

ROG Community Narratives

BA
bazza·Updated
Fair Value CHF 302.06 14.9% undervalued intrinsic discount

Roche Holding will see a 4.2576% revenue growth shaking the market

0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value CHF 300.29 14.4% undervalued intrinsic discount

Diagnostics, Pipeline And Automation Will Fuel Future Success

0users have liked this narrative
0users have commented on this narrative
128users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget·Updated
Fair Value CHF 220.00 16.9% overvalued intrinsic discount

Global Cost Controls And Biosimilar Losses Will Compress Margins

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

ROG Community Fair Values

Recent ROG News & Updates

No updates

Roche Holding AG Key Details

CHF 63.5b

Revenue

CHF 16.0b

Cost of Revenue

CHF 47.5b

Gross Profit

CHF 38.1b

Other Expenses

CHF 9.4b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
11.09
Gross Margin
74.79%
Net Profit Margin
14.85%
Debt/Equity Ratio
100.0%

Roche Holding AG Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About ROG

Founded
1896
Employees
103249
CEO
Thomas Schinecker
WebsiteView website
www.roche.com

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Swiss Market Performance

  • 7 Days: -1.2%
  • 3 Months: -1.8%
  • 1 Year: 0.6%
  • Year to Date: 2.2%
Over the last 7 days, the market has dropped 1.2%, driven by a decline of 2.8% in the Consumer Staples sector. Although the market performance has been flat over the past year. Earnings are forecast to grow by 11% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading